ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,945Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 58

$385K Total Retail Price of All Prescriptions

Rank: 18 out of 58

808 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 808 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 808 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 12,464 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$28 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AMLODIPINE BESYLATE 938 902 1 2
SIMVASTATIN 790 727 2 1
LISINOPRIL 719 658 3 3
LEVOXYL 625 572 4 34
OMEPRAZOLE 426 390 5 4
LOVASTATIN 415 412 6 15
PRAVASTATIN SODIUM 403 375 7 19
ATENOLOL 402 374 8 9
METOPROLOL TARTRATE 349 322 9 6
HYDROCODONE-ACETAMINOPHEN 343 244 S3 10 11
WARFARIN SODIUM 278 269 11 12
METFORMIN HCL 264 249 12 8
TRIAMTERENE-HCTZ 250 243 13 40
FUROSEMIDE 241 232 14 7
ZOLPIDEM TARTRATE 240 200 15 16
ALENDRONATE SODIUM 215 199 16 18
LOSARTAN POTASSIUM 214 207 17 13
HYDROCHLOROTHIAZIDE 214 193 17 10
OXYCODONE-ACETAMINOPHEN 212 141 S2 19 64
ENALAPRIL MALEATE 210 209 20 35
LANOXIN 202 196 10 21 101
NIFEDIPINE ER 194 194 22 53
SERTRALINE HCL 187 154 23 30
K-TAB 178 165 24 86
GLYBURIDE 170 170 R 25 52
TERAZOSIN HCL 147 132 26 73
VERAPAMIL ER 142 130 27 95
GEMFIBROZIL 138 134 28 56
GABAPENTIN 127 102 29 14
TRAMADOL HCL 112 73 30 20
ZOSTAVAX 104 101 31 166
RANITIDINE HCL 96 80 32 48
VENTOLIN HFA 95 84 33 91
ALLOPURINOL 94 94 34 38
ATORVASTATIN CALCIUM 91 75 35 17
LANSOPRAZOLE 85 71 36 113
PREDNISONE 82 61 37 49
FLUNISOLIDE 79 65 38 182
HYDRALAZINE HCL 78 72 39 104
DILTIAZEM 24HR CD 78 78 39 131
GLIPIZIDE 76 61 41 32
ETODOLAC 75 63 42 188
CLOPIDOGREL 74 67 43 24
BENAZEPRIL HCL 73 72 44 80
LEVOTHYROXINE SODIUM 69 63 45 5
CIPROFLOXACIN HCL 68 64 46 54
ISOSORBIDE MONONITRATE ER 68 62 46 62
CYCLOBENZAPRINE HCL 64 43 R 48 69
CLONIDINE HCL 62 56 49 45
DONEPEZIL HCL 62 62 49 29
AZITHROMYCIN 62 52 49 33
FINASTERIDE 55 55 52 84
TRICOR 53 42 53 220
CAPTOPRIL 52 52 54 223
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.